Morgan Stanley
OKYO

Morgan Stanley’s OKYO Pharma OKYO Stock Holding History

Morgan Stanley’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15 Hold
10
– – ﹤0.01% 8316
2026
Q1 		$16 Hold
10
– – ﹤0.01% 8187
2025
Q4 		$21 Buy
+10
New +$22 ﹤0.01% 8078
2024
Q1 		– Sell
-13,846
Closed -$24.5K – 7929
2023
Q4 		$24.5K Hold
13,846
– – ﹤0.01% 6392
2023
Q3 		$25.6K Buy
+13,846
New +$23.3K ﹤0.01% 6411

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Morgan Stanley's OKYO Position: Q2 2026 in Review

Morgan Stanley held its OKYO Pharma (OKYO) position steady in Q2 2026 at 10 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #8316.

Morgan Stanley first reported a position in OKYO in Q3 2023 and has held it in 5 quarters since. The position peaked at $25.6K in Q3 2023. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

  • Morgan Stanley held 10 shares of OKYO Pharma worth $15 as of Q2 2026.
  • Morgan Stanley left its OKYO Pharma share count unchanged in Q2 2026.
  • OKYO Pharma made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8316 holding.
  • Morgan Stanley first reported a position in OKYO Pharma in Q3 2023 and has held it in 5 quarters since.
  • Morgan Stanley's OKYO Pharma position peaked at $25.6K in Q3 2023.
  • 19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.